HCPLive Network
Latest Pain Management Headlines
Acetaminophen is no more effective than placebo in acute low back pain, according to a study published online July 24 in The Lancet.
By Adam Hochron
As it continues to tackle the issue of prescription drug abuse, the US Food and Drug Administration today approved an extended-release/long-acting opioid analgesic designed to help chronic pain patients while curbing their ability to tamper with it.
There has been a decrease in the number of uninsured following the open enrollment period of the Affordable Care Act, according to a report published online July 23 in the New England Journal of Medicine.
Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.
By Rachel Lutz
A wearable device for managing diabetic peripheral neuropathy has been cleared by the US Food and Drug Administration.
Blood donations to the American Red Cross are down substantially, and the agency says an "emergency situation" could arise within weeks.
High-quality studies evaluating nonoperative treatments for reducing discogenic low back pain are lacking, according to a review published in the July 15 issue of Spine.
Patient reviews indicate that the attributes most valued in physicians include interpersonal skills and bedside manner, according to a report published online July 16 by Vitals.
Preemptive treatment with oral celecoxib appears to be effective in decreasing acute postoperative pain in patients undergoing face-lift surgery, according to a study published online July 10 in JAMA Facial Plastic Surgery.
Decompression surgery in patients with lumbar spinal stenosis cuts their risk of falls, compared to similar patients utilizing nonsurgical interventions, according to a study published in the July 2 issue of The Journal of Bone & Joint Surgery.
Physician's Money Digest
If you are not using a proven investment system, then you are not likely to beat the market. A complete system should cover these 6 foundations.
While everyone's risk tolerance level is unique, it turns out individual investors typically view asset riskiness very differently than financial professionals.